Gamco Investors INC. ET AL Sells 18,447 Shares of Henry Schein, Inc. $HSIC

Gamco Investors INC. ET AL lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 4.9% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 360,949 shares of the company’s stock after selling 18,447 shares during the quarter. Gamco Investors INC. ET AL’s holdings in Henry Schein were worth $26,602,000 as of its most recent filing with the SEC.

Other hedge funds have also added to or reduced their stakes in the company. Parallel Advisors LLC boosted its stake in Henry Schein by 12.7% in the first quarter. Parallel Advisors LLC now owns 1,314 shares of the company’s stock valued at $97,000 after acquiring an additional 148 shares during the last quarter. HB Wealth Management LLC increased its stake in shares of Henry Schein by 1.3% during the 4th quarter. HB Wealth Management LLC now owns 15,034 shares of the company’s stock worth $1,136,000 after purchasing an additional 191 shares during the last quarter. Czech National Bank raised its holdings in shares of Henry Schein by 0.8% in the 4th quarter. Czech National Bank now owns 26,386 shares of the company’s stock worth $1,994,000 after purchasing an additional 206 shares during the period. Jain Global LLC raised its holdings in shares of Henry Schein by 2.0% in the 3rd quarter. Jain Global LLC now owns 10,662 shares of the company’s stock worth $708,000 after purchasing an additional 207 shares during the period. Finally, Sanctuary Advisors LLC raised its holdings in shares of Henry Schein by 4.5% in the 4th quarter. Sanctuary Advisors LLC now owns 4,856 shares of the company’s stock worth $367,000 after purchasing an additional 209 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Up 1.1%

HSIC opened at $85.47 on Friday. Henry Schein, Inc. has a 12 month low of $61.94 and a 12 month high of $89.34. The company has a market cap of $9.74 billion, a PE ratio of 25.82, a price-to-earnings-growth ratio of 1.63 and a beta of 0.81. The company has a current ratio of 1.36, a quick ratio of 0.75 and a debt-to-equity ratio of 0.59. The company has a 50 day moving average of $80.98 and a 200 day moving average of $78.04.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, May 5th. The company reported $1.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.20 by $0.12. The business had revenue of $3.37 billion for the quarter, compared to analysts’ expectations of $3.34 billion. Henry Schein had a net margin of 2.95% and a return on equity of 15.44%. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.15 EPS. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. On average, sell-side analysts expect that Henry Schein, Inc. will post 5.32 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have weighed in on HSIC shares. Mizuho reduced their price objective on Henry Schein from $88.00 to $82.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. Weiss Ratings restated a “hold (c+)” rating on shares of Henry Schein in a research note on Monday, May 4th. UBS Group reaffirmed a “neutral” rating and set a $85.00 price target (down from $87.00) on shares of Henry Schein in a research report on Wednesday, May 6th. BMO Capital Markets began coverage on Henry Schein in a research note on Wednesday, July 8th. They set a “market perform” rating and a $85.00 price target for the company. Finally, BTIG Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research note on Thursday, June 11th. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $88.62.

Insider Buying and Selling at Henry Schein

In related news, Director William K. Daniel acquired 10,000 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were bought at an average cost of $69.19 per share, for a total transaction of $691,900.00. Following the purchase, the director owned 20,000 shares in the company, valued at $1,383,800. This trade represents a 100.00% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.89% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.